Insight | D. Boral Capital

Featured Insights

March 27, 2025

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

March 26, 2025

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

March 4, 2025

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

February 28, 2025

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

February 21, 2025

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

November 25, 2024

D. Boral Capital Acted as Exclusive Placement Agent to Armlogi Holding Corp. (Nasdaq: BTOC) in connection with its up to $21 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

November 20, 2024

D. Boral Capital Served as Capital Markets Advisor to Nova Vision Acquisition Corporation (NASDAQ: NOVV) in connection with its $64.0 Million Completed Business Combination with Real Messenger

November 18, 2024

D. Boral Capital LLC to Host Inaugural DBC Conference Featuring Kevin O’Leary as Keynote Speaker

November 15, 2024

D. Boral Capital Serves as Exclusive Placement Agent to 374Water Inc. (Nasdaq: SCWO) in connection with its $12.2 Million Registered Direct Offering

November 14, 2024

D. Boral Capital Served as Exclusive Placement Agent to Pineapple Financial, Inc. (NYSE: PAPL) in connection with its $1.0 Million Registered Direct Offering

Left 1 … 4 5 6 7 8 9 Right

December 17, 2024

D. Boral Capital: Philanthropic Endeavors Continue with Donations to Keep a Child Alive and Project Rosseau

March 27, 2025

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

March 26, 2025

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

March 4, 2025

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

February 28, 2025

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

February 21, 2025

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

November 18, 2024

D. Boral Capital LLC to Host Inaugural DBC Conference Featuring Kevin O’Leary as Keynote Speaker

November 15, 2024

D. Boral Capital Serves as Exclusive Placement Agent to 374Water Inc. (Nasdaq: SCWO) in connection with its $12.2 Million Registered Direct Offering

November 14, 2024

D. Boral Capital Served as Exclusive Placement Agent to Pineapple Financial, Inc. (NYSE: PAPL) in connection with its $1.0 Million Registered Direct Offering

November 13, 2024

D. Boral Capital LLC Provides Corporate Update, Reporting Strong Revenue Growth & Financial Position

November 12, 2024

D. Boral Capital LLC to be Platinum Sponsor at The PIPEs Conference

Left 1 … 4 5 6 7 8 Right

Insights

Featured Insights

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Armlogi Holding Corp. (Nasdaq: BTOC) in connection with its up to $21 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

D. Boral Capital Served as Capital Markets Advisor to Nova Vision Acquisition Corporation (NASDAQ: NOVV) in connection with its $64.0 Million Completed Business Combination with Real Messenger

D. Boral Capital LLC to Host Inaugural DBC Conference Featuring Kevin O’Leary as Keynote Speaker

D. Boral Capital Serves as Exclusive Placement Agent to 374Water Inc. (Nasdaq: SCWO) in connection with its $12.2 Million Registered Direct Offering

D. Boral Capital Served as Exclusive Placement Agent to Pineapple Financial, Inc. (NYSE: PAPL) in connection with its $1.0 Million Registered Direct Offering

D. Boral Capital: Philanthropic Endeavors Continue with Donations to Keep a Child Alive and Project Rosseau

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

D. Boral Capital LLC to Host Inaugural DBC Conference Featuring Kevin O’Leary as Keynote Speaker

D. Boral Capital Serves as Exclusive Placement Agent to 374Water Inc. (Nasdaq: SCWO) in connection with its $12.2 Million Registered Direct Offering

D. Boral Capital Served as Exclusive Placement Agent to Pineapple Financial, Inc. (NYSE: PAPL) in connection with its $1.0 Million Registered Direct Offering

D. Boral Capital LLC Provides Corporate Update, Reporting Strong Revenue Growth & Financial Position

D. Boral Capital LLC to be Platinum Sponsor at The PIPEs Conference

Recent Transactions

October 24, 2024

Li Bang International Corporation Inc.

$6,080,000

October 23, 2024

HUHUTECH International Group Inc.

$4,200,000

September 23, 2024

Zhibao Technology Inc.

$7,200,000

September 26, 2024

Acri Capital Acquisition Corporation Merger with Foxx Development Holdings Inc.

~$50,000,000

October 4, 2024

Humacyte, Inc.

$30,000,000

September 20, 2024

Haoxi Health Technology Limited

$12,000,000

Follow Us